Changes of hippocampal Cu/Zn-superoxide dismutase after kainate treatment in the rat

Brain Research

Volumn 853, Issue 2, 2000, Pages 215-226

  Kim, Hyoung Chun ^a   Bing, Guoying ^b   Jhoo, Wang Kee ^a   Ko, Kwang Ho ^c   Kim, Won Ki ^d   Suh, Jeong Hye ^a   Kim, Seong Jin ^e   Kato, Kanefusa ^f   Hong, Jau Shyong ^g  

^a Department of Pharmacy   (South Korea)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c Sch Pharm Ctr Biofunctional M   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e NATIONAL CANCER INSTITUTE   (United States)

^f INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^g NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Astrocyte; Cu,Zn superoxide dismutase; Free radical; Hippocampus; Kainic acid; Microglia; Neurodegeneration; Superoxide

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID; MESSENGER RNA; SUPEROXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ASTROCYTES; BLOTTING, NORTHERN; ENZYME ACTIVATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; LECTINS; MALE; MICROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; S100 PROTEINS; SUPEROXIDE DISMUTASE;

EID: 0033988983     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02254-4     Document Type: Article

References (61)

1. Akai F., Maeda M., Suzuki K., Inagaki S., Taniguchi N. Immuno-cytochemical localization of manganese superoxide dismutase (Mn-SOD) in the hippocampus of the rat. Neurosci. Lett. 115:1990;19-23.
2. Andersson P.B., Perry V.H., Gordon S. The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience. 42:1991;201-214.
3. Ashwood T.J., Wheal H.V. Extracellular studies on the role of N-methyl-D-aspartate receptors in epiletiform activity recorded from kainic acid lesioned hippocampus. Neurosci. Lett. 67:1986;147-152.
4. Bidmon H.J., Oermann E., Schleisher A., Kato K., Kinscherf R., Buchkremer-Ratzmann I., Witt O.W., Zilles K. Copper-zinc superoxide dismutase and isolectin B4 binding are markers for associative and transhemispheric diaschisis induced by focal ischemia in rat cortex. Neurosci. Lett. 228:1997;163-166.
5. Bindokas V.P., Jordan J., Lee C.C., Miller R.J. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 15:1996;1324-1336.
6. Bondy S.C., LeBel C.P. The relationship between excitotoxity and oxidative stress in the central nervous system. Free Radical Biol. Med. 14:1993;633-642.
7. Bondy S.C., Lee D.K. Oxidative stress induced by glutamate receptor agonists. Brain Res. 610:1993;229-233.
8. Bose R., Schell C.L., Pinsky C., Zitko V. Effects of excitotoxin on free radical indices in mouse brain. Toxicol. Lett. 60:1992;211-219.
9. Bruce A.J., Baudry M. Oxygen free radicals in rat limbic structures after kainic acid-induced seizures. Free Radical Biol. Med. 18:1995;993-1002.
10. Carswell H.V., Graham D.I., Stone T.W. Kainate-evoked release of adenosine from the hippocampus of the anesthetized rat: possible involvement of free radicals. J. Neurochem. 68:1997;240-247.
11. Ceballos-Picot I., Nicobe A., Briand P., Grimber G., Delacourte A., Defossez A., Javoy-Agid F., Lafon M., Blouin J.L., Sinet P.M. Neuronal-specific expression of human copper-zinc superoxide dismutase in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res. 552:1991;198-214.
12. Cheng Y., Sun A.Y. Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons. Neurochem. Res. 19:1994;1557-1564.
13. Choi D.W. Ionic dependence of glutamate neurotoxocity. J. Neurosci. 7:1987;369-379.
14. Colton C.A., Gilbert D.L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 223:1987;284-288.
15. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
16. Coyle J.T., Oster-Granite M.L., Reeves R.H., Gearhart J.D. Down syndrome, Alzheimer's disease and the trisomy 16 mouse. Trends Neurosci. 11:1988;390-394.
17. Crapo J.D., McCord J.M., Fridovich I. Preparation and assay of superoxide dismutase. Methods Enzymol. 53:1978;382-393.
18. 5]enkephalin on interleukin-1 β secretion from microglia in mixed brain cell cultures. J. Neuroimmunol. 62:1995;9-17.
19. Delabar J.M., Nicobe A., D'Auriol L., Jacob Y., Meunier-Rotoval M., Galibert F., Sinet P.M., Jeromw H. Cloning and sequencing of rat Cu,Zn superoxide dismutase cDNA; Correlation between Cu,Zn superoxide dismutase mRNA level and enzyme activity in rat and mouse tissues. Eur. J. Biochem. 166:1987;81-187.
20. Dobashi K., Asayama K., Kato K., Kobayashi M., Kawaoi A. Immunohistochemical localization of copper-zinc and manganese superoxide dismutase in rat tissues. Acta Histochem. Cytochem. 22:1989;351-365.
21. Dynkens J.A., Stren A., Trenkner E. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem. 49:1987;1222-1228.
22. Fariello R.G., Golden G.T., Smith G.G., Reyes P.F. Potentiation of kainic acid epiletogenicity and sparing from neuronal damage by NMDA receptor antagonist. Epilepsy Res. 3:1989;206-213.
23. Foster A.C., Mena E.E., Monaghan D.T., Cotman C.W. Synaptic localization of kainic acid binding sites. Nature. 289:1981;73-75.
24. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
25. Hirata H., Cadet J.L. Kainate-induced hippocampal DNA damage is attenuated in superoxide dismutase transgenic mice. Mol. Brain Res. 48:1997;145-148.
26. Hong J.S., McGinty J.F., Lee P.H.K., Xie C.W., Mitchell C.L. Relationship between hippocampal opioid peptides and seizures. Prog. Neurobiol. 40:1993;507-538.
27. Jørgensen M.B., Finsen B.R., Jensen M.B., Castellano B., Diemer N.H., Zimmer J. Microglial and astroglial reaction to ischemic and kainic acid-induced lesions of the adult rat hippocampus. Exp. Neurol. 120:1993;70-88.
28. Khurgel M., Koo A.C., Ivy G.O. Selective ablation of astrocytes by intracerebral injections of α-aminoadipate. Glia. 16:1996;351-358.
29. Kim H.C., Bing G., Jhoo W.K., Ko K.H., Kim W.K., Lee D.C., Shin E.J., Hong J.S. Dextromethorphan modulates the AP-1 DNA binding activity induced by kainic acid. Brain Res. 824:1999;125-132.
30. Kim H.C., Choi D.Y., Jhoo W.K., Lee D.W., Koo C.H., Kim C. Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat. Life Sci. 61:1997;PL373-381.
31. Kim H.C., Pennypacker K.R., Bing G., Bronstein D., McMillian M., Hong J.S. The effect of dextromethorphan on kainic acid-induced seizures in the rat. Neurotoxicology. 17:1996;375-386.
32. Kondo T., Reaume A.G., Huang T.T., Carlson E., Murakami K., Chen S.F., Hoffman E.K., Scott R.W., Epstein C.J., Chan P.H. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17:1997;4180-4189.
33. Kurobe N., Suzuki F., Kato K., Sato T. Sensitive immunoassay of rat superoxide dismutase: concentration in the brain, liver, and kidney are not affected by aging. Biomed. Res. 11:1990;187-194.
34. Lafon-Cazal M., Pletri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
35. Liu X.H., Kato H., Nakata N., Kogure K., Kato K. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase in rat hippocampus after transient cerebral ischemia. Brain Res. 625:1993;29-37.
36. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
37. McIntosh L.J., Cortopassi K.M., Sapolsky R.M. Glucocorticoids may alter antioxidant enzyme capacity in the brain: kainic acid studies. Brain Res. 791:1998;215-222.
38. Minc-Golomb D., Knobler H., Groner Y. Gene dosage of Cu,Zn-SOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice. EMBO J. 10:1991;2119-2124.
39. Mori N., Wada J.A., Wadanabe M., Kumashiro H. Increased activity of superoxide dismutase in kindled brain and suppression of kindled seizure following intra-amygdaloid injection of superoxide dismutase in rats. Brain Res. 557:1991;313-315.
40. Murakami K., Kondo T., Epstein C.J., Chan P.H. Overexpression of CuZn-superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice. Stroke. 28:1997;1797-1804.
41. Nadler J.V., Perry B.W., Cotman C.W. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature. 271:1978;676-677.
42. Nadler J.V., Perry B.W., Gentry C., Cotman C.W. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricullar kainic acid. J. Comp. Neurol. 192:1980;333-359.
43. Ogawa N., Asanuma M., Kondo Y., Hirata H., Nishibayashi S., Mori A. Changes in lipid peroxidation, Cu/Zn-superoxide dismutase and its mRNA following an intracerebroventricular injection of 6-hydroxydopamine in mice. Brain Res. 646:1994;337-340.
44. Okabe M., Saito S., Saito T., Ito K., Kimura S., Nioka T., Kurasaki M. Histochemical localization of superoxide dismutase activity in rat brain. Free Radical Biol. Med. 24:1998;1470-1476.
45. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
46. Olney J.W., De Gubareff T., Collins J.F. Streospecificity of the gliotoxic and anti-neurotoxic actions of alpha-aminoadipate. Neurosci. Lett. 19:1980;277-282.
47. Pennypacker K.R., Hong J.S., McMillian M. Implications of prolonged expression of fos-related antigens. Trends Pharmacol. Sci. 16:1995;317-321.
48. Peres-Otano I., McMillian M., Chen J., Bing G., Hong J.S., Pennypacker K.R. Induction of NF-κB-like transcription factors in brain areas susceptible to kainate toxicity. Glia. 16:1996;306-315.
49. Pinard E., Tremblay E., Ben-Ari Y., Seylaz J. Blood flow compensates oxygen demand in the vulnerable CA3 region of the hippocampus during kainate-induced seizures. Neuroscience. 13:1984;1039-1049.
50. Racine R.J. Modification of seizure activity by electrical stimulation: motor seizure. EEG Clin. Neurophysiol. 32:1972;281-294.
51. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson, Goto J., O'Regan J.P., Deng H., Rahmani Z., Kirzus A., McKenna D., Cayabyab A., Gaston S.M., Tanzi R., Halperin J.J., Herzfeldt B., Van Den Bergh R., Hung W., Bird T., Mudler D.W., Smyth C., Laing N.G., Haines J., Gusella J.S., Horvitz H.R. Jr., Brown R.H. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
52. Schwob J.E., Fuller T., Price J.L., Olney J.W. Widespread pattern of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience. 5:1980;991-1014.
53. 2+-peameable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2414-2419.
54. 3-induced epileptogenic foci in the art brain. Epilepsia. 31:1990;15-26.
55. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 412:1994;1-32.
56. Sperk G., Lassman H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
57. 4). J. Histochem. Cytochem. 38:1990;1683-1686.
58. Sun A., Cheng Y., Bu Q., Oldfield F. The biochemical mechanisms of the excitotoxicity of kainic acid. Mol. Chem. Neuropathol. 17:1992;51-63.
59. Thomas W.E. Brain macrophages: evaluation of microglia and their functions. Brain Res. Rev. 17:1992;61-74.
60. 3 injection into rat isocortex. Brain Res. 277:1983;393-396.
61. Wilson J.X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75:1997;1149-1163.